Miltenyi Biomedicine
Meghan Monzon is currently serving as the Executive Director Market Access and New Business Development at Miltenyi Biomedicine. Prior to this role, they held positions such as Global Director Business Development and Alliance Management at Miltenyi Biotec. With a Bachelor of Science in Biochemistry from the University of California, Davis, Meghan has also worked in various roles within the biotechnology industry, including Clinical Applications Manager, Technical Sales Consultant, and Marketing Sales Specialist. Prior to their tenure at Miltenyi Biotec, Meghan worked as a Manufacturing Technician at Immuno Concepts.
This person is not in any offices
Miltenyi Biomedicine
2 followers
Miltenyi Biomedicine is a biopharmaceutical company that develops innovative cell and gene therapies. We are committed to bring cancer treatments and regenerative therapies to patients with unmet medical needs worldwide. We work in partnership with physicians and other healthcare providers to expand access to new therapies. Our clinical research program includes: CAR T, CAR NK, our proprietary Adapter CAR™ and induced pluripotent stem cells (iPSC) technologies. For more information, please visit our website at www.miltenyibiomedicine.com.